MATINAS BIOPHARMA HOLDINGS, INC. Operating Loss Carryforwards
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Operating Loss Carryforwards of $38.08 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-03-31
- 2025-12-31: Operating Loss Carryforwards $38.08M.
- 2024-12-31: Operating Loss Carryforwards $38.08M.
- 2023-12-31: Operating Loss Carryforwards $38.08M.
- 2021-12-31: Operating Loss Carryforwards $38.10M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $38.08M 10-K · filed 2026-03-31 |
| 2024-12-31 | $38.08M 10-K · filed 2025-04-15 |
| 2023-12-31 | $38.08M 10-K · filed 2024-03-27 |
| 2021-12-31 | $38.10M 10-K · filed 2023-03-15 |
| 2020-12-31 | $38.10M 10-K · filed 2021-03-29 |
| 2019-12-31 | $64.90M 10-K · filed 2020-03-09 |
| 2018-12-31 | $50.40M 10-K · filed 2019-04-01 |
| 2017-12-31 | $37.90M 10-K · filed 2018-03-16 |
| 2016-12-31 | $25.30M 10-K · filed 2017-03-31 |
| 2015-12-31 | $19.20M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |